TY - JOUR
T1 - Chronic circadian disruption on a high-fat diet impairs glucose tolerance
AU - Zitting, Kirsi Marja
AU - Vetrivelan, Ramalingam
AU - Yuan, Robin K.
AU - Vujovic, Nina
AU - Wang, Wei
AU - Bandaru, Sathyajit S.
AU - Quan, Stuart F.
AU - Klerman, Elizabeth B.
AU - Scheer, Frank A.J.L.
AU - Buxton, Orfeu M.
AU - Williams, Jonathan S.
AU - Duffy, Jeanne F.
AU - Saper, Clifford B.
AU - Czeisler, Charles A.
N1 - Funding Information:
This study was supported by a grant from the National Institute on Aging ( P01 AG009975 ) and a grant from the National Institute of Diabetes and Digestive and Kidney Diseases ( R01 DK127254 ). The animal studies were conducted at the Beth Israel Deaconess Medical Center. The human studies were conducted at the Brigham and Women's Hospital Center for Clinical Investigation, with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center ( National Center for Advancing Translational Sciences , National Institutes of Health Award UL1 TR002541 ) and financial contributions from Brigham and Women's Hospital , Harvard University , and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health. KMZ was supported in part by a fellowship from the Finnish Cultural Foundation . RV was supported by R01 NS088482. RKY was supported by T32 HL007901 and F32 HL143893. NV was supported by T32 HL007901 and F32 AG051325. EBK was supported by in part by K24-HL105664, R01 HL128538, and R01 GM105018. FAJLS was supported in part by R01 HL118601, R01 DK099512, R01 DK102696, R01 DK105072 and R01 HL140574. CBS was supported in part by P01 HL095491, and R01 NS085477.
Funding Information:
This study was supported by a grant from the National Institute on Aging (P01 AG009975) and a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK127254). The animal studies were conducted at the Beth Israel Deaconess Medical Center. The human studies were conducted at the Brigham and Women's Hospital Center for Clinical Investigation, with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR002541) and financial contributions from Brigham and Women's Hospital, Harvard University, and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health. KMZ was supported in part by a fellowship from the Finnish Cultural Foundation. RV was supported by R01 NS088482. RKY was supported by T32 HL007901 and F32 HL143893. NV was supported by T32 HL007901 and F32 AG051325. EBK was supported by in part by K24-HL105664, R01 HL128538, and R01 GM105018. FAJLS was supported in part by R01 HL118601, R01 DK099512, R01 DK102696, R01 DK105072 and R01 HL140574. CBS was supported in part by P01 HL095491, and R01 NS085477.
Publisher Copyright:
© 2022
PY - 2022/5
Y1 - 2022/5
N2 - Background: Nearly 14% of Americans experience chronic circadian disruption due to shift work, increasing their risk of obesity, diabetes, and other cardiometabolic disorders. These disorders are also exacerbated by modern eating habits such as frequent snacking and consumption of high-fat foods. Methods: We investigated the effects of recurrent circadian disruption (RCD) on glucose metabolism in C57BL/6 mice and in human participants exposed to non-24-h light-dark (LD) schedules vs. those on standard 24-h LD schedules. These LD schedules were designed to induce circadian misalignment between behaviors including rest/activity and fasting/eating with the output of the near-24-h central circadian pacemaker, while minimizing sleep loss, and were maintained for 12 weeks in mice and 3 weeks in humans. We examined interactions of these circadian-disrupted schedules compared to control 24-h schedules with a lower-fat diet (LFD, 13% in mouse and 25–27% in humans) and high-fat diet (HFD, 45% in mouse and 45–50% in humans). We also used young vs. older mice to determine whether they would respond differently to RCD. Results: When combined with a HFD, we found that RCD caused significant weight gain in mice and increased body fat in humans, and significantly impaired glucose tolerance and insulin sensitivity in both mice and humans, but this did not occur when RCD was combined with a LFD. This effect was similar in both young and older mice. Conclusion: These results in both humans and a model organism indicate that circadian disruption has an adverse effect on metabolism among individuals eating a high-fat Western-style diet, even in the absence of significant sleep loss, and suggest that reducing dietary fat may protect against the metabolic consequences of a lifestyle (such as shift work) that involves chronic circadian disruption.
AB - Background: Nearly 14% of Americans experience chronic circadian disruption due to shift work, increasing their risk of obesity, diabetes, and other cardiometabolic disorders. These disorders are also exacerbated by modern eating habits such as frequent snacking and consumption of high-fat foods. Methods: We investigated the effects of recurrent circadian disruption (RCD) on glucose metabolism in C57BL/6 mice and in human participants exposed to non-24-h light-dark (LD) schedules vs. those on standard 24-h LD schedules. These LD schedules were designed to induce circadian misalignment between behaviors including rest/activity and fasting/eating with the output of the near-24-h central circadian pacemaker, while minimizing sleep loss, and were maintained for 12 weeks in mice and 3 weeks in humans. We examined interactions of these circadian-disrupted schedules compared to control 24-h schedules with a lower-fat diet (LFD, 13% in mouse and 25–27% in humans) and high-fat diet (HFD, 45% in mouse and 45–50% in humans). We also used young vs. older mice to determine whether they would respond differently to RCD. Results: When combined with a HFD, we found that RCD caused significant weight gain in mice and increased body fat in humans, and significantly impaired glucose tolerance and insulin sensitivity in both mice and humans, but this did not occur when RCD was combined with a LFD. This effect was similar in both young and older mice. Conclusion: These results in both humans and a model organism indicate that circadian disruption has an adverse effect on metabolism among individuals eating a high-fat Western-style diet, even in the absence of significant sleep loss, and suggest that reducing dietary fat may protect against the metabolic consequences of a lifestyle (such as shift work) that involves chronic circadian disruption.
UR - http://www.scopus.com/inward/record.url?scp=85126555651&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126555651&partnerID=8YFLogxK
U2 - 10.1016/j.metabol.2022.155158
DO - 10.1016/j.metabol.2022.155158
M3 - Article
C2 - 35150732
AN - SCOPUS:85126555651
SN - 0026-0495
VL - 130
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
M1 - 155158
ER -